Estudio de pembrolizumab con quimiorradioterapia concomitante seguido de pembrolizumab con o sin olaparib en el cáncer de pulmón de células no pequeñas en estadio III
The purpose of this study is to assess the efficacy and safety of pembrolizumab in combination with concurrent chemoradiation therapy followed by either pembrolizumab with olaparib placebo (Arm 1) or with